A smart, home device to check personalized drug levels
Official title: SCH: Toward a smart, home-use system for noninvasive, personalized monitoring of drug levels
Funded at Oregon State University · NIH-11162391 · Data updated 2026-11-12
This project aims to create a smart, at-home device that can quickly and personally check medication levels using saliva, especially for people with epilepsy taking anti-seizure drugs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon State University NIH-funded |
| Lab location | 1 site (Corvallis, United States) |
| Project start | September 1, 2024 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $289,620 |
| NIH project number | 5R01EB036841-02 |
| Project ID | NIH-11162391 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for future involvement or benefit would be individuals with epilepsy who take anti-seizure medications and could benefit from personalized, noninvasive drug monitoring.
✕Less likely to help
Patients who do not take anti-seizure medications or those without epilepsy may not directly benefit from this specific drug monitoring technology.
What this research studies
We are working to develop a new system that lets you check your medication levels at home, without needing frequent blood tests. This system would use advanced AI and data science to understand how your body uses medication and provide real-time updates on your drug levels. Our goal is to make it easier for you and your doctor to find the perfect dose of your anti-seizure medication, helping to manage your condition more effectively. We plan to test this system by measuring anti-seizure medication levels in saliva for people with epilepsy.
Why it matters
Potential benefit: If successful, this system could lead to more personalized and effective drug dosing, potentially reducing side effects and improving treatment outcomes for patients.
How similar studies have gone: This project proposes an innovative approach by combining frequent noninvasive measurements with AI and data science for personalized drug monitoring, which is a relatively new and untested combination.
Where this research is happening
-
Oregon State University
Corvallis, United States Active
Researchers
- Principal investigator: Ramsey, Stephen a. — Oregon State University
- Study coordinator: Ramsey, Stephen a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.